Predictive value of the neutrophil‑to‑lymphocyte ratio and hemoglobin insystemic lupus erythematosus

Yu,Haitao; Jiang,Lili; Yao,Liqiong; Gan,Chao; Han,Xinwen; Liu,Ruiqi; Su,Na

doi:10.3892/etm.2018.6309

Predictive value of the neutrophil‑to‑lymphocyte ratio and hemoglobin insystemic lupus erythematosus

Authors:
- Haitao Yu
- Lili Jiang
- Liqiong Yao
- Chao Gan
- Xinwen Han
- Ruiqi Liu
- Na Su
View Affiliations

Affiliations: Department of Clinical Laboratory, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, School of Material Science and Technology, Lanzhou University of Technology, Lanzhou, Gansu 730050, P.R. China, Department of Orthopaedics, The First Hospital of Lanzhou University, Lanzhou, Gansu 730000, P.R. China, Department of Clinical Laboratory, The First Clinical Medical College of Lanzhou University, Lanzhou, Gansu 730000, P.R. China
Published online on: June 13, 2018 https://doi.org/10.3892/etm.2018.6309
Pages: 1547-1553

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to evaluate the association of the neutrophil‑to‑lymphocyte ratio (NLR) and hemoglobin levels with disease activity in patients with systemic lupus erythematosus (SLE) and to explore their clinical significance in predicting SLE. The present study included 212 patients with SLE and 201 healthy controls. All the clinical characteristics were collected from their medical records. The results revealed that the NLR was elevated and the hemoglobin level was markedly decreased in the patients with SLE compared with the healthy controls. NLR was positively correlated with the SLE Disease Activity Index 2000 (SLEDAI‑2K), erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP), whereas it was not correlated with C3 or C4. The hemoglobin level was negatively correlated with SLEDAI‑2K, ESR and CRP and positively correlated with C3 and C4. In addition, NLR [EXP(B)=1.986; 95% confidence interval (CI), 1.432‑2.753; P=0.001] and hemoglobin [EXP(B)=0.947; 95% CI, 0.929‑0.965; P=0.001] were independent predictive factors of SLE. The optimal NLR cut‑off value for predicting SLE was 2.075, with 71.14% sensitivity and 69.57% specificity, whereas the optimal hemoglobin cut‑off value was 131.5 mg/l, with 75.79% sensitivity and 77.98% specificity. In addition, high NLR together with low hemoglobin levels and high NLR or low hemoglobin levels had increased positive predictive values (86.05 and 66.95, respectively). High NLR with low hemoglobin levels and high NLR or low hemoglobin levels also had higher sensitivity (64.91 and 92.40, respectively) and specificity (64.91 and 18.95, respectively), compared with high NLR alone or low hemoglobin alone. In conclusion, NLR and hemoglobin may reflect SLE disease activity and may be used as markers for predicting the outcome of SLE.

View Figures

View References

1	Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R, Le Chen S and Zhang NZ: Rheumatic diseases in China. Arthritis Res Ther. 10:R172008. View Article : Google Scholar : PubMed/NCBI
2	Liu CC and Ahearn JM: The search for lupus biomarkers. Best Pract Res Clin Rheumatol. 23:507–523. 2009. View Article : Google Scholar : PubMed/NCBI
3	Yuan J, Li LI, Wang Z, Song W and Zhang Z: Dyslipidemia in patients with systemic lupus erythematosus: Association with disease activity and B-type natriuretic peptide levels. Biomed Rep. 4:68–72. 2016. View Article : Google Scholar : PubMed/NCBI
4	Urowitz MB, Isenberg DA and Wallace DJ: Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: Results of phase II study. Lupus Sci Med. 2:e0001042015. View Article : Google Scholar : PubMed/NCBI
5	Osei-Bimpong A, Meek JH and Lewis SM: ESR or CRP? A comparison of their clinical utility. Hematology. 12:353–357. 2007. View Article : Google Scholar : PubMed/NCBI
6	Gaitonde S, Samols D and Kushner I: C-reactive protein and systemic lupus erythematosus. Arthritis Rheum. 59:1814–1820. 2008. View Article : Google Scholar : PubMed/NCBI
7	Petri M: Disease activity assessment in SLE: Do we have the right instruments? Ann Rheum Dis. 66 Suppl 3:iii61–iii64. 2007. View Article : Google Scholar : PubMed/NCBI
8	Afari ME and Bhat T: Neutrophil to lymphocyte ratio (NLR) and cardiovascular diseases: An update. Expert Rev Cardiovasc Ther. 14:573–577. 2016. View Article : Google Scholar : PubMed/NCBI
9	Balta S, Celik T, Mikhailidis DP, Ozturk C, Demirkol S, Aparci M and Iyisoy A: The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost. 22:405–411. 2016. View Article : Google Scholar : PubMed/NCBI
10	Kim DS, Shin D, Lee MS, Kim HJ, Kim DY, Kim SM and Lee MG: Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 43:305–310. 2016. View Article : Google Scholar : PubMed/NCBI
11	Hu ZD, Sun Y, Guo J, Huang YL, Qin BD, Gao Q, Qin Q, Deng AM and Zhong RQ: Red blood cell distribution width and neutrophil/lymphocyte ratio are positively correlated with disease activity in primary Sjögren's syndrome. Clin Biochem. 47:287–290. 2014. View Article : Google Scholar : PubMed/NCBI
12	Sen BB, Rifaioglu EN, Ekiz O, Inan MU, Sen T and Sen N: Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis. Cutan Ocul Toxicol. 33:223–227. 2014. View Article : Google Scholar : PubMed/NCBI
13	Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, Hu Z, Liang Y, Yang Z and Zhong R: Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 26:372–376. 2016. View Article : Google Scholar : PubMed/NCBI
14	Moller B, Scherer A, Förger F, Villiger PM and Finckh A: Swiss Clinical Quality Management Program for Rheumatic Diseases, Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: A prospective cohort study. Ann Rheum Dis. 73:691–696. 2014. View Article : Google Scholar : PubMed/NCBI
15	van Steenbergen HW, van Nies JA and van der Helm-van Mil AH: Anaemia to predict radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 72:e162013. View Article : Google Scholar : PubMed/NCBI
16	Smyrnova G: The relationship between hemoglobin level and disease activity in patients with rheumatoid arthritis. Rev Bras Reumatol. 54:437–440. 2014.(In Portuguese). View Article : Google Scholar : PubMed/NCBI
17	Gladman DD, Ibañez D and Urowitz MB: Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 29:288–291. 2002.PubMed/NCBI
18	Zahorec R: Ratio of neutrophil to lymphocyte count-rapid and simple parameter of systemic inflammation in critically ill. Bratisl Lek Listy. 102:5–14. 2001.(In English, Slovak). PubMed/NCBI
19	Ahsen A, Ulu MS, Yuksel S, Demir K, Uysal M, Erdogan M and Acarturk G: As a new inflammatory marker for familial Mediterranean fever: Neutrophil-to-lymphocyte ratio. Inflammation. 36:1357–1362. 2013. View Article : Google Scholar : PubMed/NCBI
20	Wu Y, Chen Y, Yang X, Chen L and Yang Y: Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus. Int Immunopharmacol. 36:94–99. 2016. View Article : Google Scholar : PubMed/NCBI
21	Stohl W, Hiepe F, Latinis KM, Thomas M, Scheinberg MA, Clarke A, Aranow C, Wellborne FR, Abud-Mendoza C, Hough DR, et al: Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus. Arthritis Rheum. 64:2328–2337. 2012. View Article : Google Scholar : PubMed/NCBI
22	Hashimoto M, Fujii T, Hamaguchi M, Furu M, Ito H, Terao C, Yamamoto K, Yamamoto W, Matsuo T, Mori M, et al: Increase of hemoglobin levels by anti-IL-6 receptor antibody (tocilizumab) in rheumatoid arthritis. PLoS One. 9:e982022014. View Article : Google Scholar : PubMed/NCBI
23	Isaacs JD, Harari O, Kobold U, Lee JS and Bernasconi C: Effect of tocilizumab on haematological markers implicates interleukin-6 signalling in the anaemia of rheumatoid arthritis. Arthritis Res Ther. 15:R2042013. View Article : Google Scholar : PubMed/NCBI